KEGG   DRUG: Emtricitabine and tenofovir alafenamideHelp
Entry
D10835            Mixture   Drug                                   

Name
Emtricitabine and tenofovir alafenamide;
Descovy (TN)
Product
Component
Emtricitabine [DR:D01199], (Tenofovir alafenamide fumarate [DR:D10605] | Tenofovir alafenamide [DR:D10428])
Remark
Therapeutic category: 6250
ATC code: J05AR17
Product: D10835<JP/US>
Efficacy
Antiviral
  Disease
HIV infection [DS:H01563]
Comment
Tenofovir alafenamide is a substrate of cathepsin A, CYP3A and P-gp.
Metabolism
Enzyme: CTSA [HSA:5476], CYP3A [HSA:1576 1577 1551]
Transporter: ABCB1 [HSA:5243]
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AR Antivirals for treatment of HIV infections, combinations
     J05AR17 Emtricitabine and tenofoviralafenamide
      D10835  Emtricitabine and tenofovir alafenamide <JP/US>
USP drug classification [BR:br08302]
 Antivirals
  Anti-HIV Agents, Other
   Emtricitabine/ Tenofovir Alafenamide Fumarate
    D10835  Emtricitabine and tenofovir alafenamide
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  62  Chemotherapeutics
   625  Antivirals
    6250  Antivirals
     D10835  Emtricitabine and tenofovir alafenamide
Antiinfectives [br08350.html]
 Antivirals
  D10835
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10835
BRITE hierarchy
Other DBs
PubChem: 319902635
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system